MicroAlgo Inc. (the "Company" or "MicroAlgo") (NASDAQ: MLGO), today announced the proposal of a powerful solution—a multi-objective evolutionary search strategy, which is an innovative automated tool ...

The quest for true randomness has roots in cryptography and is a rabbit hole that gets surprisingly deep with alarmingly ...

Learn how AI medical discovery is bridging the gap between lab research and bedside treatments, resulting in faster and more ...

MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the "Company"), a technology service provider, is committed to ...

This is the second trial at Weill Cornell Medicine to incorporate use of Nociscan.

Speaking at WSJ Opinion Live in Washington, D.C., WSJ Editorial Page Editor Paul Gigot and SandboxAQ CEO Jack Hidary discuss Large Quantitative Models (LQMs) and their role in AI applications, the ...

Palbociclib plus exemestane with GnRH agonist vs capecitabine in premenopausal patients with HR+/HER2- metastatic breast cancer: Updated survival results of the randomized phase 2 study Young-PEARL.

Whole-blood transfusion has recently gained favor in the management of severe hemorrhage; however, data from large clinical trials evaluating its clinical effectiveness and safety are lacking. We ...

A new study published today in Nature has found that X’s algorithm – the hidden system or “recipe” that governs which posts appear in your feed and in which order – shifts users’ political opinions in ...